Pharmaniaga (7081.KL) Earnings Analysis
Pharmaniaga (7081.KL) next reports earnings on 2026-08-14. Last quarter (2026-05-19) it missed with EPS 0.00501 MYR vs 0.00533 MYR est (-6%). It has beaten estimates in 0/1 recent quarters (0%). Trailing P/E 20.71.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 7081.KL next report earnings?
| Next earnings date | 2026-08-14 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
7081.KL earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-19 | 0.00501 MYR | 0.00533 MYR | -6% | Miss |
| 2026-02-23 | 0.002 MYR | n/a | n/a | n/a |
| 2025-11-13 | 0.003 MYR | n/a | n/a | n/a |
| 2025-08-26 | 0.003 MYR | n/a | n/a | n/a |
| 2025-02-28 | 0.00095 MYR | n/a | n/a | n/a |
| 2024-11-26 | 0.3505 MYR | n/a | n/a | n/a |
| 2024-08-21 | 0.00119 MYR | n/a | n/a | n/a |
Beat rate: 0/1 (0%) over reported quarters with consensus data.
7081.KL valuation and analyst view
| Trailing P/E | 20.71 |
|---|---|
| Trailing EPS | 0.03843 MYR |
| Price / book | 3.30 |
| Dividend yield | 1.07% |
| Market cap | 1.55B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Pharmaniaga (7081.KL)'s next earnings date?
Pharmaniaga is next scheduled to report on 2026-08-14.
Did 7081.KL beat earnings last quarter?
In its 2026-05-19 report, 7081.KL posted EPS of 0.00501 MYR versus a 0.00533 MYR estimate — a miss of 6%.
What is 7081.KL's earnings track record?
Over the last 1 reported quarters with consensus data, 7081.KL beat estimates 0 times (0%).
What is 7081.KL's current P/E ratio and EPS?
7081.KL trades at a trailing P/E of 20.71 on trailing EPS of 0.0384335884032774 MYR.
What do analysts rate 7081.KL?
7081.KL has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.